20321 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
COMPOSITIONS AND THERAPEUTIC METHODS FOR TREATING CHRONIC SEQUALAE FOLLOWING VIRAL INFECTIONS
#2METHOD OF TREATMENT
#3COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#4COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#5IDENTIFICATION AND USE OF SHP2 CONFORMATIONAL DISRUPTORS FOR CANCER TREATMENT
#6CBL-B INHIBITORS AND ANTI-PD1/ANTI-PD-L1 FOR USE IN THE TREATMENT OF CANCER
#7COMPOSITION FOR MITOCHONDRIAL MODIFICATION COMPRISING A COMBINATION OF TWO OR MORE NATURAL PIGMENTS
#8PEGYLATED BILIRUBIN FOR THE TREATMENT OF HYPERLIPIDEMIA, OBESITY, FATTY LIVER DISEASE, CARDIOVASCULAR DISEASES AND TYPE II DIABETES
#9SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION
#10Piezo Inhibition for Wound Healing
#11EMULSION FOR NON-INVASIVE BLOOD-BRAIN BARRIER TRANSIENT OPENING AND CONTROLLED DRUG RELEASE INTO THE BRAIN
#12CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY
#13METHODS TO ENHANCE THERAPEUTIC EFFICACY IN MELANOMA VIA MODULATION OF CELL SURFACE PD-L1/L2
#14FERROCHELATASE INHIBITORS AND METHODS OF USE
#15COMPOSITIONS OF FOLATE ABSORPTION INHIBITORS AND METHODS THEREOF
#16PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT COMPOUND CONJUGATED TO G4 STRUCTURES OF CORONAVIRUSES FOR PREVENTION OR TREATMENT OF CORONAVIRUS INFECTIOUS DISEASES
#17Use of Verteporfin to Modulate Wound Healing After an Ocular Surgical Procedure or Ocular Injury
#18Use of Chlorophyll Derivatives for the Treatment of SARS-CoV-2 Infection
#19PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS
#20PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS
#21COMPOSITION FOR INCREASING MUSCLE MASS AND SUPPRESSING A DECREASE IN MUSCLE MASS, AND COMPOSITION FOR INCREASING MUSCLE MASS AND SUPPRESSING MUSCLE ATROPHY
#22NUTRACEUTICAL COMPOSITION FOR DELIVERY OF HYDROPHILIC AND HYDROPHOBIC BIOACTIVE SUBSTANCES
#23COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#24TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
#25COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA
#26COMPOSITIONS AND THERAPEUTIC METHODS FOR TREATING CHRONIC SEQUALAE FOLLOWING VIRAL INFECTIONS
#27Nanocrystals, compositions, and methods that aid particle transport in mucus
#28COMPOSITIONS AND METHODS FOR ADMINISTERING A YAP1/WWRT1 INHIBITING COMPOSITION AND A GLS1 INHIBITING COMPOSITION
#29NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#30PARTICLES INCLUDING CHITOSAN-BILIRUBIN CONJUGATE, AND ORAL PHARMACEUTICAL COMPOSITION INCLUDING SAME
#31Methods of treating patients at risk for renal injury and renal failure
#32Subterranean microalgae for production of microbial biomass, substances, and compositions
#33COMPOSITION AND METHOD FOR MODULATING FIBROBLAST GROWTH FACTOR RECEPTOR 3 ACTIVATION
#34PTEN inhibitors for treatment and prevention of bone marrow loss
#35SARS-COV-2 INHIBITORS
#36Nanocrystals, compositions, and methods that aid particle transport in mucus
#37COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE
#38DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS
#39PHARMACEUTICAL COMPOSITIONS WITH ANTIFLAVIVIRAL ACTIVITY
#40Iron compositions and methods of making and using the same
#41Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#42PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING FIBROSIS, COMPRISING PHEOPHORBIDE COMPOUND AS ACTIVE INGREDIENT
#43MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES LOADED WITH AT LEAST ONE PHOTOSENSITIZER AND USES THEREOF FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS
#44METHODS FOR TREATING INJURY ASSOCIATED WITH EXPOSURE TO AN ALKYLATING SPECIES
#45COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS
#46YAP Inhibition for Wound Healing
#47COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE
#48Iron compositions and methods of making and using the same
#49USE OF INHIBITORS OF YAP/TAZ FOR THE TREATMENT OF CANCER
#50COMBINATIONAL THERAPIES FOR TREATMENT OF CANCER COMPRISING A BACTERIOCHLOROPHYLL DERIVATIVE
#51PHARMACEUTICAL AGENTS TARGETING CANCER STEM CELLS
#52METHODS FOR TREATING CUTANEOUS METASTATIC CANCERS
#53PHARMACEUTICAL USE OF CHLOROPHYLLIDE FOR CANCER THERAPY
#54PHARMACEUTICAL USE OF CHLOROPHYLLIDE FOR ANTI-VIRAL INFECTION
#55PEGYLATED BILIRUBIN FOR THE TREATMENT OF HYPERLIPIDEMIA, OBESITY, FATTY LIVER DISEASE, CARDIOVASCULAR DISEASES AND TYPE II DIABETES
#56SUPRAMOLECULAR PHOTOPROTECTION OF A PHOTOSENSITIZER
#57METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER
#58METHOD FOR TREATING CANCER WITH KIDNEY PROTECTION
#59USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
#60COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#61COMPOSITION FOR SUPRESSING SECRETION OF EXTRACELLULAR VESICLES
#62SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY
#63Methods for radiotherapy to trigger light activation drugs
#64POLYMER-PARTICLE LIGHT-CLEAVABLE CARRIER SYSTEMS FOR PHOTODYNAMIC THERAPY
#65Method for long-term storage of chlorophyll-containing extract
#66Corroles for treating human cytomegalovirus infections
#67NOVEL HYDROGEL CONJUGATES
#68SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#69METHOD FOR PREPARING CHLOROPHYLL-CONTAINING EXTRACT
#70DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS
#71METHODS AND COMPOSITIONS FOR TREATING HETEROTOPIC OSSIFICATION
#72Compositions Containing Verteporfin, Ribavirin, Gemcitabine, or Combinations Thereof and Methods of Use for Treating COVID-19, Cancer, or Non Cancer Diseases
#73Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#74Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
#75Treating and preventing disease with TMA and TMAO lowering agents
#76Corroles for treating poxvirus infection
#77Compositions and methods for treating pulmonary vascular disease
#78Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease
#79COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE
#80Nanocrystals, compositions, and methods that aid particle transport in mucus
#81Ferrochelatase inhibitors and methods of use
#82Reduced adaptive microbial resistance treatment for flesh eating disease (necrotizing fasciitis)
#83Methods and compositions to enhance metabolic detoxification systems
#84SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY
#85SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#86TREATMENT OF CHOLANGIOCARCINOMA WITH TPCS-2A INDUCED PHOTOCHEMICAL INTERNALISATION OF GEMCITABINE
#87Sonodynamic therapy using microbubbles and pulsed wave ultrasound methods and systems
#88Iron compositions and methods of making and using the same
#89Chlorin-vitamin conjugates
#90COMPOSITIONS AND METHODS FOR ADMINISTERING A YAP1/WWRT1 INHIBITING COMPOSITION AND A GLS1 INHIBITING COMPOSITION
#91Subterranean microalgae for production of microbial biomass, substances, and compositions
#92PIM kinase inhibitors in combination with autophagy inhibitors for treatment of cancers
#93Derivatives of porphyrins, their process of preparation and their use for treating viral infections
#94Treating and preventing disease with TMA and TMAO lowering agents
#95Methods of treating resistant cancers
#96Methods of treating patients at risk for renal injury and renal failure
#97SPECIFICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PHOTODYNAMIC THERAPY
#98Method and apparatus for determining acetabular component positioning
#99TREATMENT OF AGE RELATED MACULAR DEGENERATION WITH A SMALL ACTIVE CHOROIDAL NEOVASCULARIZATION LESION
#100Composition and method for modulating fibroblast growth factor receptor 3 activation
#101Composition for the prevention and/or treatment of cardiovascular diseases
#102Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
#103Photodynamic therapeutic compounds and photodynamic methods of treatment
#104Compositions and methods for treating pulmonary vascular disease
#105YAP1 inhibitors and methods
#106Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
#107Northern-southern route to synthesis of bacteriochlorins
#108Chlorin-vitamin conjugates
#109Calixpyrrole-based antitumor compounds
#110Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
#111Atropisomers of halogenated tetraphenylbacteriochlorins and chlorins and their use in photodynamic therapy
#112Pharmaceutical compositions with antiflaviviral activity
#113Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
#114SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY
#115Pharmaceutical agents targeting cancer stem cells
#116IDENTIFICATION OF ADDITIONAL ANTI-PERSISTER ACTIVITY AGAINST BORRELIA BURGDORFERI FROM AN FDA DRUG LIBRARY
#117Methods and Compositions for Treating Conditions of the Eye
#118X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
#119Methods and products for preventing and/or treating microorganism infections comprising iron chelators and non-iron porphyrins
#120Methods for radiotherapy to trigger light activation drugs
#121TRIPLET-TRIPLET ANNIHILATION-BASED UPCONVERSION
#122Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease
#123Nanocrystals, compositions, and methods that aid particle transport in mucus
#124Improved Hyaluronan and Modified-Hyaluronan in Biomedical Applications
#125Treatment for myopathy
#126Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
#127METHOD FOR PRODUCTION OF INSULIN-PRODUCING CELLS
#128Platelet-like proteo-microparticles and method of using such in drug delivery
#129Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
#130Composition comprising a photosensitive compound in a polymeric nanoparticle, and a method of using the composition
#131Inhibition of YAP for breaking tumor immune tolerance
#132Eutectic solvents and uses thereof
#133TREATMENT OF AGE RELATED MACULAR DEGENERATION WITH A SMALL ACTIVE CHOROIDAL NEOVASCULARIZATION LESION
#134COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION
#135Nanocrystals, compositions, and methods that aid particle transport in mucus
#136Targeting-enhanced anticancer nanoparticles and preparation methods of same
#137SMC combination therapy for the treatment of cancer
#138Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
#139Method for the identification of immunotherapy-drug combinations using a network approach
#140Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties
#141Chlorophyll c containing degranulation suppressor
#142Composition for improving skin conditions, containing chlorophyll a or pheophorbide a
#143TREATMENT OF PEROXISOME BIOGENESIS DISORDER
#144Nanocrystals, compositions, and methods that aid particle transport in mucus
#145Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#146DVDMS sensitizer for cancer sonodynamic therapy
#147Cell penetrating peptides for intracellular delivery of molecules
#148Phthalocyanine derivative consisting of a mixture of 4 isomers
#149PHOTODYNAMIC THERAPY USING IN SITU NONLINEAR PHOTON UPCONVERSION OF NIR LIGHT BY BIOLOGICAL MEDIUM
#150Methods for cross-linking corneal collagen with verteporfin for the treatment of disorders of the eye
#151Compositions useful in alleviating pulmonary congestion and uses thereof
#152Methods of treating skin disorders
#153Derivative of styrene-maleic acid copolymer
#154Castration-resistant prostate cancer
#155COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INVOLVING HIPPO PATHWAY
#156Nanocrystals, compositions, and methods that aid particle transport in mucus
#157Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
#158Continuous long-term controlled release of telomerase inhibitors
#159Inhibition of ferrochelatase as an antiangiogenic therapy
#160Compound and method for vaccination and immunisation
#161Composition for controlling a gut immunity and use thereof
#162Antioxidatively Active Composition and the Use Thereof
#163HPPH lyophilized powder injection for injection and preparation method thereof
#164Use of a photosensitive agent capable of producing reactive oxygen species in the production of a drug for the photodynamic therapy of a disease related to stem cells, in vitro use, and pharmaceutical composition
#165Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
#166Targeting-enhanced anticancer nanoparticles and preparation methods of same
#167Method of treatment of disease
#168Nanocrystals, compositions, and methods that aid particle transport in mucus
#169Nanocrystals, compositions, and methods that aid particle transport in mucus
#170Metalloporphyrin neurological treatments
#171PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF PHOTOSENSITIZERS AND USES THEREOF
#172COMBINATION THERAPY
#173Extract of L
#1745, 10, 15, 20-tetrakis (carboxyphenyl) porphine (TCPP) and kit for use with detecting cancer
#175Cancer treatment
#176Composition of chlorin e6 stabilized within albumin for the photodynamic diagnosis and therapy of tumors
#177Abnormal electrical conduction blocking apparatus using photodynamic therapy (PDT)
#178Phthalocyanine compounds useful as RecA inhibitors and methods of using same
#179Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy
#180Chlorophyll c containing degranulation suppressor
#181Small molecule modulators of pRb inactivation
#182Compositions and methods for reducing photosensitivity associated with photodynamic therapy
#183Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation by using tumor proliferation inhibitor and low-intensity pulsed ultrasound waves
#184Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting
#185ADAPTER FOR ACETABULAR COMPONENT POSITIONING
#186Stability in Vitamin and Mineral Supplements
#187Extract of L
#188SERIES OF DRUGS USING PHOTOFRIN TO CATALYZE DECOMPOSITION OF HYDROGEN PEROXIDE
#189Therapeutic meso-biliverdin IXα compositions and associated methods
#190Photodynamic therapy or diagnostic agent, using infrared-spectrum light
#191Nanocrystals, compositions, and methods that aid particle transport in mucus
#192Molecular switch
#193USE OF ORGANIC COMPOUNDS
#194Adapter for acetabular component positioning
#195Methods for treatment of sleep-related breathing disorders
#196Method and composition for administering bioactive compounds derived from
#197Composite comprising at least one type of perfluoroalkyl-perfluoro-phthalocyanine
#198Method and apparatus for determining acetabular component positioning
#199Method and apparatus for determining acetabular component positioning
#200MEDICINAL TARGETED LOCAL LIPOLYSIS
#201VISION THROUGH PHOTODYNAMIC THERAPY OF THE EYE
#202Drug delivery system and method of treatment of vascular diseases using photodynamic therapy
#203DERMATOLOGICAL TREATMENT DEVICE
#204Glyco-substituted dihydroxy-chlorins and β-functionalized chlorins for anti-microbial photodynamic therapy
#205Dynamic colorectal PDT application
#206Substituted porphyrins
#207Method for treating neovascularization
#208METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#209TREATMENT OF HEPATITIS C VIRUS INFECTIONS
#210PHOTODYNAMIC THERAPEUTIC AGENT HAVING CELL-SPECIFIC ACTIVE ACCUMULATION PROPERTIES
#211METHODS TO ENHANCE NIGHT VISION AND TREATMENT OF NIGHT BLINDNESS
#212Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
#213PHTHALOCYANINE DERIVATIVE CONSISTING OF A MIXTURE OF 4 ISOMERS
#214Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
#215RETINITIS PIGMENTOSA TREATMENT
#216COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF
#217METHOD OF PROVIDING NEUROPROTECTION USING SUBSTITUTED PORPHYRINS
#218Photodynamic therapy for conditions of the eye
#219NIOSOME HAVING METAL PORPHYRIN COMPLEX EMBEDDED THEREIN, PROCESS FOR PRODUCING THE SAME AND DRUG WITH THE USE THEREOF
#220Porphyrazine optical and dual optical/MR contrast and therapeutic agents
#221LIGHT-ACTIVATED DISINFECTION SYSTEM
#222Methods of inhibiting microbial biofilms
#223REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS
#224INHIBITION OF BRAIN ENZYMES INOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION
#225Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage
#226Cyclic tetrapeptides
#227Methods and Compositions for Treating Conditions of the Eye
#228DEVICE FOR PHOTODYNAMICAL THERAPY OF CANCER
#229PDT treatment method for cellulites and cosmetic use
#230Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
#231Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
#232Use of Green Porphyrins to Treat Neovasculature in the Eye
#233Methods for treating injury associated with exposure to an alkylating species
#234Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors
#235Oxidant scavengers for treatment of type I diabetes or type II diabetes
#236CORROLES FOR NEUROPROTECTION AND NEURORESCUE
#237Substituted porphyrins
#238Acylated phthalocyanines
#239Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy
#240Oral formulations for tetrapyrrole derivatives
#241Method for Enhancing Pdt Efficacy Using a Tyrosine Kinase Inhibitor
#242Methods for diagnosing bowel disease
#243METHODS OF USING NITROXIDES IN CONJUNCTION WITH PHOTOSENSITIZERS AND SONOSENSITIZERS
#244SIMULTANEOUS PHOTODYNAMIC THERAPY AND PHOTO INDUCED POLYMERIZATION
#245Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
#246PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY
#247Compositions for inhibiting NADPH oxidase activity
#248Composition and method for the control of organoleptic properties of bodily fluids and secretions
#249TREATMENT OF ESOPHAGEAL HIGH GRADE DYSPLASIA USING PHOTODYNAMIC THERAPY
#250Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
#251ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS
#252Treatment of Hepatitis C Infection With Metalloporphyrins
#253Photodynamic therapy for the treatment of acne
#254Treatment for cutaneous metastases
#255LIPOSOMAL GEL PHTHALOCYANINE PREPARATION FOR PHOTODYNAMIC THERAPY OF TUMORS AND ITS MANUFACTURING
#256INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION
#257Abnormal electrical conduction blocking apparatus using photodynamic therapy (PDT)
#258Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets
#259Method and apparatus for determining acetabular component positioning
#260Method for Treating Body Fluid
#261Agent for improving circulatory disorder
#262Medicinal targeted local lipolysis
#263PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A FUNGAL SKIN DISORDER AND A METHOD FOR THE PREPARATION THEREOF
#264Topical delivery of phthalocyanines
#265CASPASE INHIBITOR
#266Self-sterilizing products
#267Compositions and methods for reducing photosensitivity associated with photodynamic therapy
#268Polymeric pharmaceutical agent for treatment of cancer and method for production of the same
#269Method for inhibiting infection and reproduction of influenza type A WSN virus
#270Antiviral therapies
#271Drug for Treating or Diagnosing Vascular Lesion in the Skin or the Subcutaneous Soft Tissue Caused by Light Irradiation
#272INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION
#273Method for making 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine (TCPP) solution and composition comprising TCPP
#274Water soluble compounds
#275USE OF A MAGNESIUM ISOTOPE FOR TREATING HYPOXIA AND A MEDICAMENT COMPRISING THE SAME
#276Ingestible Plaque Eliminator for Animals
#277Ingestible Malodor Eliminator for Animals
#278Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
#279Use of green porphyrins to treat neovasculature in the eye
#280BLOCKERS OF PORE-FORMING VIRULENCE FACTORS AND THEIR USE AS ANTI-INFECTIVES
#281Stability in vitamin and mineral supplements
#282Photosensitizer formulations and their use
#283PHARMACEUTICAL USE OF NITRIC OXIDE, HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#284Substituted Porphyrins
#285Method for treating neovascularization
#286Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins
#287Use Of Organic Compounds
#288OXIDANT SCAVENGERS FOR TREATMENT OF DIABETES OR USE IN TRANSPLANTATION OR INDUCTION OF IMMUNE TOLERANCE
#289PORPHYRIN OXYGEN INFUSION FOR INCREASING CONCENTRATIONS IN TUMOR TISSUES
#290Topical Skin Compositions, Their Preparation, and Their Use
#291Topical Skin Compositions, Their Preparation, and Their Use
#292Catatonic bacteriochlorophyll derivatives
#293Medical Use of Bilirubin and its Structural Analogues
#294Vision through photodynamic therapy of the eye
#295PHOTODYNAMIC THERAPY FOR THE TREATMENT OF HAIR LOSS
#296Porphyrin derivatives and their use in photon activation therapy
#297Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration
#298Stroller with spring-assisted fold mechanism
#299Auger effect-based cancer therapy method
#300Light activated antiviral materials and devices and methods for decontaminating virus infected environments